Currently out of the existing stock ratings of Priyanka Grover, 4 are a BUY (100%).

Priyanka Grover

Work Performance Price Targets & Ratings Chart

Analyst Priyanka Grover, currently employed at JPMORGAN,

Priyanka Grover’s has documented 8 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RLAY, Relay Therapeutics at 14-Aug-2026.

Wall Street Analyst Priyanka Grover

Analyst best performing recommendations are on RYTM (RHYTHM PHARMACEUTICALS).
MREO Mereo BioPharma Group PLC ADR RLAY Relay Therapeutics RYTM Rhythm Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$5

$3.13 (167.38%)

$7

1 years 2 months 24 days ago
(10-Jul-2025)

0/14 (0%)

$3.31 (195.86%)

Buy

$7

$5.13 (274.33%)

$7

1 years 6 months 16 days ago
(18-Mar-2025)

2/9 (22.22%)

$4.47 (176.68%)

339

Buy

$8

$6.13 (327.81%)

$8

2 years 3 months 14 days ago
(20-Jun-2024)

0/2 (0%)

$4.11 (105.66%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Priyanka Grover most bullish on?

Potential upside of $53.17 has been obtained for RYTM (RHYTHM PHARMACEUTICALS)

Which stock is Priyanka Grover most reserved on?

Potential downside of $12.04 has been obtained for RLAY (RELAY THERAPEUTICS)

What Year was the first public recommendation made by Priyanka Grover?

On 2026
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?